Welcome to our dedicated page for PMGC Holdings news (Ticker: ELAB), a resource for investors and traders seeking the latest updates and insights on PMGC Holdings stock.
PMGC Holdings Inc. reports news across a holding-company portfolio that includes precision manufacturing, aerospace and defense supply-chain operations, industrial packaging, defense technology, and bioscience subsidiaries. Recurring company updates cover subsidiary long-term supply agreements, ITAR and aerospace quality standards, customer relationships, manufacturing capacity, and capital actions tied to acquisition-led platform development.
PMGC news also covers NorthStrive Biosciences patent filings and manufacturing work for engineered probiotic assets such as EL-22 and EL-32, as well as Pacific Sun Packaging activity in electronics and IT hardware packaging markets. Defense technology announcements describe subsidiary initiatives involving autonomous systems, counter-drone applications, and GPS-denied navigation environments.
NorthStrive Biosciences (NASDAQ: ELAB) announced on April 13, 2026 the U.S. transfer of its EL-32 Working Cell Bank (WCB) to a third-party fermentation facility and the start of a manufacturing optimization program to raise yield and enable scalable, cost-efficient production.
EL-32 is a dual-action engineered probiotic targeting myostatin and activin-A pathways to help preserve lean muscle during GLP-1 therapy. Collaboration with Modulant Biosciences covers process development for animal-health products while NorthStrive retains human therapeutic rights, aiming to support IND-enabling activities and future GMP manufacturing.
Pacific Sun Packaging (NASDAQ: ELAB) will exhibit at ITAD Europe 2026 on April 15–16, 2026 in Nice, France, marking an expansion of its international presence.
The company will present protective packaging for high-value IT hardware at Booth #414, targeting global buyers, recyclers, and enterprise decision-makers across the ITAD and circular electronics supply chain.
AGA Precision Systems (Nasdaq: ELAB) executed a second long-term agreement on April 9, 2026, with a globally recognized Tier 1 aerospace and defense customer to supply precision CNC-manufactured components for multi-year programs. The LTA formalizes future purchase orders and includes defined performance commitments for quality, delivery, and pricing.
AGA said the agreement reinforces its qualified-supplier status, supports recurring revenue potential, and increases operational visibility while the customer identity remains confidential due to ITAR and regulatory obligations.
PMGC Holdings (NASDAQ: ELAB) has fully utilized a $20.0 million equity purchase facility with Streeterville Capital, strengthening cash to fund near-term acquisitions.
PMGC closed four precision manufacturing and specialty packaging acquisitions from July 2025–February 2026 and advances Northstrive Biosciences' EL-22 toward a Phase 2 IND pathway.
NorthStrive Defense Tech (NASDAQ: ELAB) acquired an exclusive option to license U.S. Patent No. 12,291,334 for a multi-domain drone system that transports cable-suspended payloads through water while flying above the surface. Key capabilities include buoyancy-assisted payload efficiency, trajectory optimization, and operation in coastal, riverine, and flood-prone areas.
The Option Agreement allows development and financing during the Option Period; exercise would trigger negotiation of a definitive license to commercialize the technology. No guarantee of a final license or commercialization is provided.
PMGC Holdings (NASDAQ: ELAB) announced the formation of a wholly owned subsidiary, NorthStrive Defense Tech LLC, to target defense technology with emphasis on drones, autonomous systems, and unmanned defense solutions.
The subsidiary will pursue acquisitions, licensing, and partnerships and plans to leverage PMGC's existing operating subsidiaries, AGA Precision Systems and Silicon Valley Machining, to accelerate commercialization. The company warned there is no assurance these efforts will generate revenue or operational success and said a follow-up announcement is planned.
AGA Precision Systems (NASDAQ: ELAB) executed a Long-Term Agreement (LTA) with Turbo-Jet Products on March 31, 2026 to supply mission-critical aerospace and defense components.
The LTA establishes a five-year initial term with annual renewal provisions and governs future purchase orders, supporting regulated U.S. government and defense-related programs. AGA cites its AS9100 certification and ITAR compliance as enablers for quality, traceability, and regulatory adherence.
PMGC Holdings (NASDAQ: ELAB) filed its Form 10-K for fiscal year ended December 31, 2025, reporting a year of capital deployment and asset growth. Total assets rose 43% to approximately $12.87M and shareholders' equity increased to about $7.84M.
The company completed three acquisitions in 2025 (Pacific Sun Packaging on July 7, AGA Precision Systems on July 18, and Indarg Engineering on Oct 26) to expand precision manufacturing and specialty IT packaging operations, and advanced biopharma subsidiary Northstrive with clinical and preclinical programs targeting muscle preservation alongside GLP-1 therapies.
NorthStrive Biosciences (NASDAQ: ELAB) announced a third amendment to its License Agreement with MOA Life Plus (KOSDAQ: 142760) covering dual myostatin assets EL-32 and EL-22.
The Amendment updates the timing and key development milestones for human clinical programs, aligning schedules with both parties' R&D and regulatory expectations and reinforcing disciplined development planning for the human health portfolio.
PMGC (NASDAQ: PMGC) announced that its wholly owned subsidiary SVM Machining completed ITAR registration on March 24, 2026 and is in compliance with U.S. export‑control rules.
The company said the registration enables SVM to pursue defense and aerospace programs, increases eligibility as a qualified supplier to Tier 1 defense contractors and supports PMGC's strategy to expand into high‑value, defense‑related manufacturing.